Welcome to AiCuris: The Powerhouse for Anti-Infectives
AiCuris (from 'Anti-infective Cures') is a pharmaceutical company focused exclusively on the discovery, research and development of novel antiviral and antibacterial agents for the treatment of severe and potentially life-threatening infectious diseases.
Founded in 2006 from Bayer's virology and bacteriology research divisions, AiCuris today has an innovative pipeline of novel anti-infectives and a team of internationally regarded scientists and drug developers. With its tight focus on specialist markets with high medical need, the company is perfectly positioned for growth and success.
Dr. Zimmermann elected as board member of BioDeutschland
The annual meeting of BioDeutschland, including the election of a new board, took place on 5th of October. The new board of BioDeutschland consists of ten biotech executives including the AiCuris CEO Holger Zimmermann.
European Business Dev. Conference
Join AiCuris at European Business Development Conference
for Biotech & Pharma 2015 November 23-24 in Antwerp, Belgium. Listen to the the AiCuris company presentation
on November 23 rd , 3:15pm CET.
Join AiCuris and its quest for novel Anti-Infectives
We offer an exciting and challenging working enviroment in an innovative company with a world-class R&D Portfolio.